Substitution of the Normal Levels of Iron and Hemoglobin in Pregnant Women With Iron Supplement

Prevention of Anemia Clinical Trial

Official title:

Treatment of Iron Defieciency Anemia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02957643
• Other study ID #: HippokratioGH
• Status: Completed
• Phase: Phase 1/Phase 2
• Start date: November 2016
• Est. completion date: September 1, 2017

Study information

• Verified date: July 2020
• Source: Hippocration General Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of the study is to investigate the effectiveness of iron in the treatment of iron deficiency in pregnant 2nd and 3rd quarter. Every 30 days the investigators measure the hemoglobin, hematocrit and iron in serum and assess the course of treatment.

Description:

The purpose of the study is to investigate the effectiveness of iron in the treatment of iron deficiency in pregnant 2nd and 3rd quarter. Every 30 days the investigators measure the hemoglobin, hematocrit and iron in serum and assess the course of treatment

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: September 1, 2017
• Est. primary completion date: September 2017
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

1. Age more or equal of 18 years

2. Registration consent

3. Have complete 12h week of pregnancy

4. Hemoglobin levels <10,5 ptl

5. Hematocrit < 32 %

Exclusion Criteria:

1. Age <18 years

2. Absent registration consent

3. Step of pregnancy less than 12 weeks

4. Coadministration formulations iron oral or parenterally

5. Background of liver kirrosis

6. Background of aimosidirosis

7. Background acquired or chronic aimatochromatosis

8. Aplastic , Hemolytic anemia and chronic diseases

9. Chronic pancreatitis

10. Subjective renal or/and liver disease

11. Hypothyroidism or yperthyreoeidismos

Related Conditions & MeSH terms

• Anemia
• Prevention of Anemia

Intervention

Drug:
• Iron
oral treatment

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Hippocration General Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Measured and reported effectiveness of iron in the treatment of iron deficiency in pregnant 2nd and 3rd quarter with questionnaire	Measured and reported effectiveness of iron in the treatment of iron deficiency in pregnant	up to 24 months
Secondary	adverse reactions	adverse reactions	up to 24 months